NFCR Announces Childhood Cancer Research Match in Collaboration with the Rally Foundation
In February 2024, NFCR President and CEO Sujuan Ba, Ph.D., participated in the first global OncoThon event co-hosted by Oncoheroes Biosciences, a biotech company dedicated to pediatric cancer and is a recipient of long-term support from NFCR through our AIM-HI Translational Research Initiative. Dr. Ba joined fellow community leaders, including the Rally Foundation for Childhood Cancer CEO Dean Crowe, to raise awareness for pediatric cancer research.
Click now: https://www.nfcr.org/blog/...
In February 2024, NFCR President and CEO Sujuan Ba, Ph.D., participated in the first global OncoThon event co-hosted by Oncoheroes Biosciences, a biotech company dedicated to pediatric cancer and is a recipient of long-term support from NFCR through our AIM-HI Translational Research Initiative. Dr. Ba joined fellow community leaders, including the Rally Foundation for Childhood Cancer CEO Dean Crowe, to raise awareness for pediatric cancer research.
Click now: https://www.nfcr.org/blog/...
NFCR Announces $200,000 Research Match for Pediatric Cancers
Rally Foundation CEO Dean Crowe offered a $200,000 match for pediatric cancers and NFCR's Dr. Ba proudly pledged to help. Give Now!
https://www.nfcr.org/blog/nfcr-announces-childhood-cancer-research-match-in-collaboration-with-the-rally-foundation/
02:18 AM - Jul 08, 2024
Only people mentioned by nfcr_usa in this post can reply
